Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of JKN2306 tablets for postoperative pain after orthopedic surgery
CTR20263712Phase 2Active
- Sponsor
- Joincare Pharmaceutical
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JKN2306 in acute pain, postoperative pain, sponsored by Joincare Pharmaceutical. Started Oct 2026; status: active.
02
Drugs
JKN2306
03
Conditions
acute painpostoperative pain
Beyond the preview
Go deeper on CTR20263712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263712.